Other Assets, Noncurrent in USD of Ambrx Biopharma Cayman, Inc. from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Other Assets, Noncurrent history and change rate from Q4 2020 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Other Assets, Noncurrent for the quarter ending 30 Jun 2023 was $357,000.000, a 23.4% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2023 $357,000 -$109,000 -23.4% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $380,000 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $339,000 -$191,000 -36% 31 Dec 2022 10-Q 09 Aug 2023
Q2 2022 $466,000 30 Jun 2022 6-K 29 Aug 2022
Q4 2021 $530,000 -$94,000 -15.1% 31 Dec 2021 10-K 30 Mar 2023
Q4 2020 $624,000 31 Dec 2020 20-F 26 Apr 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.